Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-17

Clinical Trial Update: Corifollitropin Alfa Versus Recombinant Follicle Stimulating Hormone (FSH) in Ovarian Stimulation of Women Undergoing in Vitro Fertilisation [Phase 1, Phase 2]

View source ↗

Summary

A clinical trial comparing corifollitropin alfa with recombinant FSH for ovarian stimulation in IVF, completed phases 1 and 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Corifollitropin alfa (Corifollitropin alfa)
  • recombinant follicle-stimulating hormone (recombinant follicle-stimulating hormone)

Snippet

Sponsor: National and Kapodistrian University of Athens | Conditions: Infertility | Phase 1, Phase 2 | Status: COMPLETED